Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
SSKN logo SSKN
Upturn stock rating
SSKN logo

STRATA Skin Sciences Inc (SSKN)

Upturn stock rating
$1.78
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

10/31/2025: SSKN (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $8

1 Year Target Price $8

Analysts Price Target For last 52 week
$8 Target price
52w Low $1.38
Current$1.78
52w High $3.86

Analysis of Past Performance

Type Stock
Historic Profit -5.92%
Avg. Invested days 13
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/31/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 10.12M USD
Price to earnings Ratio -
1Y Target Price 8
Price to earnings Ratio -
1Y Target Price 8
Volume (30-day avg) 2
Beta 0.51
52 Weeks Range 1.38 - 3.86
Updated Date 11/1/2025
52 Weeks Range 1.38 - 3.86
Updated Date 11/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.84

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -35.13%
Operating Margin (TTM) -29.02%

Management Effectiveness

Return on Assets (TTM) -11.13%
Return on Equity (TTM) -235.41%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 21293225
Price to Sales(TTM) 0.31
Enterprise Value 21293225
Price to Sales(TTM) 0.31
Enterprise Value to Revenue 0.65
Enterprise Value to EBITDA -7008.83
Shares Outstanding 5684508
Shares Floating 1691948
Shares Outstanding 5684508
Shares Floating 1691948
Percent Insiders 10.13
Percent Institutions 57.24

ai summary icon Upturn AI SWOT

STRATA Skin Sciences Inc

stock logo

Company Overview

overview logo History and Background

STRATA Skin Sciences, Inc. (formerly PhotoMedex, Inc.) was founded in 1989. The company focuses on developing and commercializing innovative products for the treatment of dermatological conditions. Over the years, STRATA has evolved through acquisitions and internal development, solidifying its position in the medical dermatology market.

business area logo Core Business Areas

  • Dermatology Devices: STRATA Skin Sciences develops, markets, and sells medical devices used in the treatment of various skin conditions, including psoriasis, vitiligo, and acne.
  • Pharma: STRATA develops and markets pharma solutions for skin conditions

leadership logo Leadership and Structure

The leadership team consists of the CEO, CFO, and other key executives overseeing various departments such as marketing, sales, R&D, and operations. The organizational structure is typically hierarchical, with functional departments reporting to executive management.

Top Products and Market Share

overview logo Key Offerings

  • XTRAC Laser: The XTRAC laser system is used for the treatment of psoriasis and vitiligo. Market share data for XTRAC is difficult to ascertain as it depends on the specific market segment (psoriasis/vitiligo devices). Key competitors include laser systems from companies like Candela and Cutera. Revenue figures for XTRAC are not publicly available.
  • PHAROS Excimer Laser: PHAROS is another excimer laser used to treat skin conditions, similar to XTRAC. Market share and revenue data are not broken out separately for PHAROS. Competitors are the same as XTRAC.
  • Rhofade (oxymetazoline HCl) cream, 1%: Rhofade is a topical medication indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. Competitors include Mirvaso (brimonidine) and generics. Revenue numbers are unavailable.

Market Dynamics

industry overview logo Industry Overview

The medical dermatology device and pharma market is driven by increasing prevalence of skin conditions, advancements in technology, and growing demand for non-invasive treatment options. The market is competitive, with several established players and emerging companies.

Positioning

STRATA Skin Sciences is positioned as a key player in the dermatology market with its innovative laser systems and treatments. Their competitive advantage lies in the XTRAC laser and its effectiveness for targeted treatment.

Total Addressable Market (TAM)

The total addressable market for dermatology devices and treatments is estimated to be in the billions of dollars. STRATA is positioned to capture a portion of this market through continued product innovation and market expansion. Specific TAM figures are not readily available for their niche.

Upturn SWOT Analysis

Strengths

  • Established product portfolio
  • Strong brand recognition in the dermatology market
  • Proprietary laser technology
  • Experienced management team

Weaknesses

  • High operating expenses
  • Dependence on key products
  • Limited financial resources compared to larger competitors
  • Small market cap and stock volatility

Opportunities

  • Expansion into new geographic markets
  • Development of new products and technologies
  • Strategic partnerships and acquisitions
  • Increasing demand for non-invasive treatments

Threats

  • Intense competition
  • Regulatory changes
  • Technological obsolescence
  • Economic downturns affecting healthcare spending

Competitors and Market Share

competitor logo Key Competitors

  • CYTK
  • ALGN
  • LMNR

Competitive Landscape

STRATA Skin Sciences faces strong competition from established players in the dermatology market. They compete on product innovation, pricing, and distribution. Larger competitors have more resources for marketing and R&D.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been variable depending on product adoption and sales. Growth rates have been moderate.

Future Projections: Future projections are based on analyst estimates. These projections are not available for direct JSON output.

Recent Initiatives: Recent initiatives may include new product launches, marketing campaigns, and strategic partnerships.

Summary

STRATA Skin Sciences is a player in the dermatology market with its laser systems and treatments. Its strengths lie in the established product portfolio. The company faces challenges related to its small size, financial resources, and market competition. Growth opportunities exist through geographic expansion and new product development.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Analyst Reports (General)

Disclaimers:

Data is based on publicly available information and may not be fully comprehensive. Market share data is estimated and may not be precise. This analysis is for informational purposes only and should not be considered financial advice.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About STRATA Skin Sciences Inc

Exchange NASDAQ
Headquaters Horsham, PA, United States
IPO Launch date 2005-10-28
President, CEO & Vice-Chairman Dr. Dolev Rafaeli Ph.D.
Sector Healthcare
Industry Medical Devices
Full time employees 106
Full time employees 106

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.